CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Eurofins Viracor Launches BKV inSIGHT™ T-Cell Immunity Panel to Support BK Virus Immune Monitoring in Kidney Transplant Patients

BKV inSIGHT™ T-Cell Immunity PanelPositive
AI Analysis

Summary

Eurofins Viracor announced the commercial availability of the BKV inSIGHT™ T-Cell Immunity Panel, a novel assay designed to measure BK virus-specific T-cell immunity in kidney transplant patients. This is a routine product launch announcement with no clinical trial or regulatory catalyst.

Importance:3/10
Sentiment:
0.60
diagnosticimmunomonitoringBK viruskidney transplantcommercial launch

Read the original article

Published by PR Newswire Biotech on July 22, 2026 3:00 PM

Read Original